1:20 PM
 | 
Jan 02, 2018
 |  BC Extra  |  Politics & Policy

Biopharma champion Sen. Hatch retiring

Sen. Orrin Hatch (R-Utah), chairman of the Senate Finance Committee, announced Tuesday that he will not seek reelection in 2018. First elected in 1976, Hatch has done more to shape the legal and regulatory landscape for drug development than any other serving member of Congress. He has been the biopharma industry’s most reliable ally. The biopharma industry has supported...

Read the full 271 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >